1 

John E. Flaherty 

Jonathan M.H. Short 

McCARTER & ENGLISH, LLP 

Four Gateway Center 

100 Mulberry Street 

Newark, New Jersey 07102 

(973) 622-4444 

Attorneys for Plaintiffs 

AstraZeneca AB, AstraZeneca LP, 

KBI-E Inc., and Pozen , Inc. 

Stephen M. Hash 

Stephen C. Stout 

VINSON & ELKINS LLP 

2801 Via Fortuna, Suite 100 

Austin, TX 78746-7568 

Tel: (512) 542-8400 

Of Counsel for Plaintiff Pozen Inc.

Einar Stole 

Edward H. Rippey 

Erica Andersen 

COVINGTON & BURLING LLP 

1201 Pennsylvania Avenue, N.W. 

Washington, D.C. 20004-2401 

(202) 662-6000 

Of Counsel for Plaintiffs AstraZeneca AB, 

AstraZeneca LP, and KBI-E Inc.

Henry J. Renk 

FITZPATRICK, CELLA, HARPER 

& SCINTO 

1290 Avenue of the Americas 

New York, New York 10104-3800 

(212) 218-2100 

Of Counsel for Plaintiffs AstraZeneca AB, 

AstraZeneca LP, and KBI-E Inc.

IN THE UNITED STATES DISTRICT COURT 

FOR THE DISTRICT OF NEW JERSEY 

ASTRAZENECA AB, ASTRAZENECA LP, 

KBI-E INC., and POZEN INC., 

Plaintiffs, 

v. 

DR. REDDY'S LABORATORIES INC. and 

DR. REDDY'S LABORATORIES LTD., 

Defendants. 

Civil Action No. 3:13-cv-00091 

 (JAP)(DEA) 

(consolidated for discovery purposes 

with Civ. A. Nos. 3:11-cv-02317-JAPDEA, 3:11-cv-04275-JAP-DEA and 

3:11-cv-06348-JAP-DEA) 

Motion Date: October 7, 2013

PLAINTIFFS’ NOTICE OF MOTION FOR LEAVE TO AMEND THEIR RESPONSES 

TO DRL’S INVALIDITY CONTENTIONS 

Case 3:11-cv-02317-JAP-DEA Document 173 Filed 08/27/13 Page 1 of 4 PageID: 5837
2 

TO DR. REDDY’S LABORATORIES, LTD., DR. REDDY’S LABORATORIES, INC. AND 

THEIR ATTORNEYS OF RECORD: 

PLEASE TAKE NOTICE that Plaintiffs-Counterclaim-Defendants AstraZeneca AB, 

AstraZeneca LP, KBI-E Inc. and Pozen Inc. (collectively, “Plaintiffs”), will move before this 

Court at the United States District Court for the District of New Jersey, 402 East State Street, 

Trenton, New Jersey, on October 7, 2013 at 10:00 a.m. for entry of an Order granting Plaintiffs’ 

motion for leave to amend their Responses to Dr. Reddy’s Laboratories, Ltd. Inc. and Dr. 

Reddy’s Laboratories, Inc.’s (collectively, “DRL”) Invalidity Contentions pursuant to L. Pat. R. 

3.6(i) regarding DRL’s allegations of invalidity against all of the asserted claims of U.S. Patent 

6,926,907. 

PLEASE TAKE FURTHER NOTICE that in compliance with Local Patent Rule 3.7, 

movant states that attorneys for Plaintiffs contacted the attorney for DRL, Alan Pollack, who 

objects to the relief sought by this motion. 

PLEASE TAKE FURTHER NOTICE that Plaintiffs will rely upon the Memorandum 

submitted with this Notice of Motion, and upon all pleadings and proceedings on file herein. 

PLEASE TAKE FURTHER NOTICE that a Proposed Order granting Plaintiffs’ motion 

is attached. 

Case 3:11-cv-02317-JAP-DEA Document 173 Filed 08/27/13 Page 2 of 4 PageID: 5838
3 

Dated: August 27, 2013 Respectfully submitted, 

s/John E. Flaherty 

John E. Flaherty 

Jonathan M.H. Short 

MCCARTER &ENGLISH, LLP 

Four Gateway Center 

100 Mulberry Street 

Newark, New Jersey 07102 

(973) 622-4444 

Counsel for Plaintiffs AstraZeneca AB, 

AstraZeneca LP, KBI-E, Inc., and Pozen 

Inc. 

Einar Stole Stephen M. Hash 

Edward Rippey Stephen C. Stout 

Erica Andersen VINSON & ELKINS LLP 

COVINGTON & BURLINGTON LLP 2801 Via Fortuna 

1201 Pennsylvania Avenue, NW Suite 100 

Washington, DC 20004-2401 Austin, TX 78746-7568

(202) 662-5095 (512) 542-8504 

 

Of Counsel for Plaintiffs AstraZeneca AB Of Counsel for Plaintiff Pozen Inc.

and AstraZeneca LP 

Henry J. Renk 

FITZPATRICK, CELLA, HARPER & SCINTO

1290 Avenue of the Americas 

New York, NY 10104-3800 

(212) 218-2250 

Of Counsel for Plaintiffs AstraZeneca AB, 

AstraZeneca LP, and KBI-E Inc. 

 

Case 3:11-cv-02317-JAP-DEA Document 173 Filed 08/27/13 Page 3 of 4 PageID: 5839
4 

CERTIFICATE OF SERVICE 

I hereby certify that on August 27, 2013, I caused a true and correct copy of the foregoing 

PLAINTIFFS’ NOTICE OF MOTION FOR LEAVE TO AMEND THEIR RESPONSES TO 

DRL’S INVALIDITY CONTENTIONS and supporting documents to be served upon the 

following counsel via electronic mail and the CM/ECF system: 

Alan H. Pollack 

Stuart D. Sender 

Dmitry V. Shelhoff 

Budd Larner, PC 

150 John F. Kennedy Parkway, CN100 

Short Hills, NJ 07078-0999 

(973) 379-4800 

Counsel for Defendants Dr. Reddy's 

Laboratories, Ltd., and Dr. Reddy's 

Laboratories, Inc. 

Karen A. Confoy 

Christopher R. Kinkade 

Fox Rothschild LLP, PC 

997 Lenox Drive 

Bldg 3 

Lawrenceville, NJ 08648 

(609) 844-3033 

Counsel for Defendants Lupin Ltd. and 

Lupin Pharmaceuticals, Inc. 

Robert Green 

Jessica Tyrus 

Caryn Borg-Breen 

Christopher Griffith 

Leydig, Voit & Mayer, Ltd. 

Two Prudential Plaza 

180 N. Stetson Avenue, Suite 4900 

Chicago, IL 60601 

(312) 616-5600 

Of Counsel for Defendants Lupin Ltd. and 

Lupin Pharmaceuticals, Inc. 

Sean R. Kelly 

Katherine A. Escanlar 

SAIBER LLC 

18 Columbia Turnpike 

Florham Park, NJ 07932 

Tel: (973) 622-3333 

Counsel for Defendant Anchen 

Pharmaceuticals, Inc. 

Anthony W. Shaw 

Richard J. Berman 

Crystal R. Canterbury 

Aziz Burgy 

Bradford Frese 

Arent Fox LLP 

1050 Connecticut Avenue NW 

Washington, DC 20036-5339 

Tel: (202) 857-6000 

Of Counsel for Defendant Anchen 

Pharmaceuticals, Inc. 

By: s/John E. Flaherty 

John E. Flaherty 

Case 3:11-cv-02317-JAP-DEA Document 173 Filed 08/27/13 Page 4 of 4 PageID: 5840